Astra logo
Updated October 2025
Pediatrics • Endocrinology • Emergency Care

Pediatric Diabetic Ketoacidosis: High‑Yield Management Pearls

Evidence-based, stepwise approach to pediatric DKA with emphasis on fluid strategy, insulin dosing, electrolytes, cerebral injury prevention, and safe transitions. Integrates current pediatric guidance and risks with clinically actionable checkpoints.

Clinical question
What are the key, evidence-based management pearls for pediatric diabetic ketoacidosis (DKA) to optimize safety, minimize cerebral injury, and achieve timely resolution of acidosis?
DKAPediatricsEndocrinologyEmergency MedicineCritical CareElectrolytes
Key points
Do first, fast, and safely
Prioritize airway/breathing/circulation, obtain IV access, start isotonic fluids, and send critical labs (glucose, electrolytes, BUN/Cr, VBG, beta‑hydroxybutyrate). Avoid insulin bolus; begin insulin infusion after initial fluid resuscitation.
Fluids with intent
Use isotonic solutions; rehydrate over 36 hours. Early isotonic bolus and careful ongoing replacement are safe and do not increase cerebral edema risk; monitor corrected sodium trends.
Electrolytes drive safety
Replace potassium early unless hyperkalemic with ECG changes or anuric. Anticipate total body deficits despite initial normal/high serum K; add dextrose once glucose falls to ~250–300 mg/dL to continue insulin safely.
Prevent cerebral injury
Avoid rapid osmotic shifts, bicarbonate, and insulin bolus. Perform frequent neuro checks; treat suspected cerebral edema immediately with hypertonic therapy and escalate care.
Know when you’re done
Biochemical resolution: pH >7.30 and HCO3− >15 mmol/L with closed anion gap and tolerating PO. Overlap basal insulin prior to stopping infusion to prevent rebound ketosis.
Evidence highlights
≈0.3–0.9% of DKA episodes
Cerebral injury risk
10–20 mL/kg isotonic
Initial fluid bolus
0.05–0.1 U/kg/h (no bolus)
Insulin infusion
Initial Priorities
Stabilization and Diagnostic Baseline
Early, structured interventions decrease complications and time to resolution.
1
Airway, Breathing, Circulation
Assess ABCs. Provide oxygen only if hypoxemic. Avoid intubation unless necessary; consider increased intracranial pressure if deteriorating mental status. Establish two IV lines; place on continuous cardiorespiratory monitoring.
2
Critical Labs and Monitoring
Point-of-care glucose; VBG for pH/CO2; BMP (Na, K, Cl, HCO3, BUN/Cr), phosphate, magnesium; serum/urine ketones (prefer beta‑hydroxybutyrate), CBC if infection suspected, HbA1c if new diabetes. Baseline ECG for potassium status. Strict I/O; hourly neuro checks; hourly glucose; electrolytes every 2–4 h.
3
Initial Fluid Resuscitation
Give isotonic fluid (0.9% saline or balanced crystalloid) 10–20 mL/kg over 20–30 min. Repeat a second 10–20 mL/kg bolus for shock. After bolus(es), continue isotonic fluids to replace deficit over ~36 h with maintenance plus deficit strategy. Track corrected Na; a falling corrected Na is concerning.
4
Start Insulin After Fluids
Begin regular insulin infusion 0.05–0.1 U/kg/h 1–2 h after fluids start, without a bolus. Target glucose decline ~50–100 mg/dL/h. Add dextrose (e.g., D5–D10) to IV fluids when glucose reaches 250–300 mg/dL to continue insulin at the same rate while clearing ketones.
Safety Core
Electrolytes, Cerebral Injury Prevention, and Transitions
Electrolyte replacement and neuro-vigilance are central to safe care.
Potassium Strategy
Assume total-body K deficit; start K replacement once urine output is confirmed and K <5.5 mmol/L.
Typical: 40 mmol/L combined KCl + K acetate (or K phosphate) in fluids; titrate to keep serum K 4.0–5.0 mmol/L.
If K ≥5.5 mmol/L, hold K and monitor q1–2 h with ECG; start when K falls.
Insulin drives K intracellular; anticipate early drop in serum K and treat proactively.
Phosphate and Magnesium
Phosphate often depleted; consider replacing 20–30% of K as K phosphate if low or if hemolysis/weakness present.
Check magnesium; replete if low to reduce arrhythmia risk and aid potassium repletion.
Avoid Iatrogenesis
No insulin bolus; use continuous infusion only.
Avoid bicarbonate except for life‑threatening hyperkalemic instability or severe acidosis with cardiac compromise.
Do not overhydrate; replace over ~36 h and reassess hemodynamics frequently.
Do not chase glucose too low; add dextrose to permit ongoing insulin for ketone clearance.
Cerebral Injury Prevention and Treatment
Risk factors: young age, severe acidosis, high BUN, profound dehydration, rapid osmolar shifts.
Warning signs: headache, irritability, declining GCS, bradycardia, hypertension, incontinence, vomiting.
Immediate treatment if suspected: mannitol 0.5–1 g/kg IV over 10–15 min or hypertonic saline 3% 3–5 mL/kg IV over 10–15 min; elevate head of bed; reduce fluid rate; urgent PICU consultation.
Document hourly neuro checks; maintain normocapnia and normoxia.
Targets and Monitoring
Glucose fall: 50–100 mg/dL/h. If faster, increase dextrose rather than decrease insulin early in care.
Biochemical resolution: pH >7.30, HCO3− >15 mmol/L, anion gap closed, clinically improved perfusion.
Electrolytes q2–4 h; glucose hourly; strict I/O; weight and fluid balance charting.
Transition to Subcutaneous Insulin
When tolerating PO and DKA resolved, give long‑acting basal insulin 1–2 h before stopping infusion (or overlap with pump restart).
Resume preadmission regimen (if known) or start weight‑based basal‑bolus; ensure carbohydrate coverage and correction scale.
Provide DKA prevention education before discharge (sick‑day rules, ketone testing, insulin adherence).
Special Situations
Nuances and Practical Pearls
Tailor therapy to severity, comorbidities, and setting.
1
Young Children and Severe Acidosis
Higher vigilance for cerebral injury; consider 1:1 nursing and high-dependency/PICU for pH <7.1, altered mental status, or hemodynamic instability. Avoid rapid fluid/tonicity shifts; track corrected Na every 2–4 h.
2
Shock or Severe Dehydration
Use additional isotonic boluses (10–20 mL/kg) guided by perfusion and blood pressure. Start insulin after initial resuscitation once perfusion improves.
3
Suspected Infection or New-Onset Diabetes
Obtain cultures only if indicated by clinical exam; treat sepsis empirically per local protocol. In new-onset diabetes, plan education, basal/bolus initiation, and screening for autoimmune comorbidities after stabilization.
4
Airway Considerations
Avoid unnecessary intubation; preoxygenate and plan carefully if required due to risk of hemodynamic instability and potential intracranial pressure concerns.
At-a-Glance Dosing
Common Orders and Targets
Representative values; align with local formulary and weight-based calculators.
Fluids
Bolus: 0.9% saline 10–20 mL/kg over 20–30 min; repeat as needed for shock.
Deficit + maintenance over 36 h using isotonic base; add dextrose (D5–D10) when glucose 250–300 mg/dL.
Aim corrected Na to rise or remain stable as glucose falls.
Insulin
Regular insulin 0.05–0.1 U/kg/h IV infusion; no bolus.
Keep insulin running during dextrose escalation to clear ketones.
Target glucose decline 50–100 mg/dL/h.
Potassium
Typical replacement 40 mmol/L (mix of KCl + K acetate or K phosphate).
Hold K only if K ≥5.5 mmol/L or anuric/ECG changes; monitor frequently.
Add phosphate if low or symptomatic; replete magnesium if low.
References
Source material
Primary literature that informs this article.
www.sciencedirect.com

Managing Diabetic Ketoacidosis in Children

www.sciencedirect.com

www.sciencedirect.com/science/article/abs/pii/S0196064421001608
www.sciencedirect.com

Current understanding and management of paediatric ...

www.sciencedirect.com

www.sciencedirect.com/science/article/pii/S1751722223000732
academic.oup.com

Emergent Airway Management in Pediatrics - Oxford Academic

academic.oup.com

academic.oup.com/book/37196/chapter/327016836
academic.oup.com

National Trends in Pediatric Admissions for Diabetic ...

academic.oup.com

academic.oup.com/jcem/article/106/8/2343/6263446
link.springer.com

Diabetic Ketoacidosis in Pediatric Emergency Medicine

link.springer.com

link.springer.com/article/10.1007/s40138-025-00311-3
link.springer.com

Pediatric Diabetic Ketoacidosis

link.springer.com

link.springer.com/chapter/10.1007/978-3-319-93830-1_21
link.springer.com

Pediatric Diabetic Ketoacidosis

link.springer.com

link.springer.com/chapter/10.1007/978-3-031-32650-9_21
extranet.who.int

Guidelines on Clinical and Programmatic Management of ...

extranet.who.int

extranet.who.int/ncdccs/Data/ETH_D1_National%20NCD%20Guideline%20June%201…
www.uptodate.com

Diabetic ketoacidosis in children: Treatment and complications

www.uptodate.com

www.uptodate.com/contents/diabetic-ketoacidosis-in-children-treatment-and…
pubmed.ncbi.nlm.nih.gov

Diabetic ketoacidosis (DKA): treatment guidelines

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/8804545/
pmc.ncbi.nlm.nih.gov

Current recommendations for management of paediatric ...

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10156932/
pmc.ncbi.nlm.nih.gov

Diagnosis and treatment of diabetic ketoacidosis in ...

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC2720895/
pmc.ncbi.nlm.nih.gov

Management of diabetic ketoacidosis in children - PMC

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC10433311/